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Physicians who practice obstetrics are at risk for 
malpractice claims whenever there is a less than opti-
mal outcome.  In addition those who practice obstetrics 
pay some of the highest malpractice premiums of any 
specialty physician group.  Although not every bad 
outcome can be avoided, the practice of safe obstetrics 
can reduce this risk.  Recently, as an educational com-
ponent of the visits that the Statewide Perinatal Team 
make to each of your hospitals, I have included a dis-
cussion with those in attendance of 5 obstetrical situa-
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tions that are high risk for legal liability.  We also dis-
cuss means by which these liabilities can be decreased. 
These fi ve situations are:
1)  Fetal Heart Rate Tracings
2)  Pitocin and misoprostol (cytotec) use
3)  VBAC
4)  Shoulder Dystocia
5)  Operative Vaginal Deliveries (Forceps 
 and Vacuum)
High Risk Obstetrical Legal Situations
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High Risk OB Legal Situation #1 —Fetal Heart 
Rate Tracings
Good communication and thorough documenta-
tion can improve the odds that a lawsuit will not be 
fi led or that a lawsuit that is fi led can be successfully 
defended.  As part of achieving good communication 
when it comes to discussing fetal heart rate tracings I 
recommend that all labor and delivery personnel be-
come acquainted with and begin using the standard-
ized terminology for fetal heart rate patterns endorsed 
by the NICHD, ACOG (ACOG Practice Bulletin #62), 
and other professional societies (Table 1).  The purpose 
for this adoption is to have all care providers using the 
same terminology for interpretation of fetal monitor 
strips to ensure safe and consistent patient care.  
In addition to the need to improve our communica-
tion and documentation with respect to fetal heart rate 
monitoring a recent published article describes com-
mon mistakes in FHR monitoring and provides excel-
lent counsel on how to avoid these legal pitfalls.  The 
author describes 5 areas of concern, and I have para-
phrased these below.
a) Delayed use of internal fetal monitors.
Often patients and caregivers prefer not to use in-
ternal fetal monitors for a variety of reasons.  They are 
invasive, they may be viewed as unnatural, and they 
do have certain inherent risks.  However, internal fetal 
monitors should be liberally used in certain situations, 
including times when the fetal heart rate is diffi cult to 
pick up or interpret, if there is any question concerning 
maternal versus fetal heart rate, during preparation 
for cesarean section in the OR, and during the second 
stage of labor if external monitors are only recording 
segments of the fetal heart rate.  If an adverse neona-
tal outcome occurs, those gaps in the fetal heart rate 
monitor strip can often lead to allegations of negligent 
monitoring directed against both the physician and the 
nurses.
b) Discontinuing fetal monitoring too soon.
This often happens in situations where a reactive 
nonstress test has been achieved, however there are 
also some decelerations seen on the strip.  When this 
is seen, prolongation of the monitoring period may 
be warranted.  In addition, if delivery is thought to be 
imminent, sometimes fetal monitors are removed but 
then, for whatever reason delivery is delayed longer 
than anticipated.  This may result in  several min-
utes where no fetal monitoring is obtained.
c) Not adequately monitoring the fetus during place-
ment of conduction anesthesia.
Placement of conduction anesthesia can take time, 
especially in diffi cult patients (obese, scoliosis etc). 
Patterns in fetal heart rate may change during or after 
placement of conduction anesthesia.  Changes in ma-
ternal position during placement of conduction anes-
thesia may make recording of fetal heart tones diffi -
cult, especially if external monitors are being utilized. 
For these reasons it is important to monitor the fetus at 
least intermittently during these episodes.  If possible 
internal monitoring should be considered.
d) Not monitoring the fetus in the OR.
The time from decision to incision for a cesarean sec-
tion may differ due to the indications for the cesarean 
section.  This time period may be increased in hospitals 
where the surgical team is not immediately available 
in the hospital. A considerable amount of time may 
pass between discontinuing fetal monitoring in the 
labor room and delivery of the fetus in the OR.  It is 
important to continue to assess fetal well being during 
this time.  If possible, internal fetal monitors should 
be used during this preparatory time.  I suggest that if 
internal monitors can be used that they be left on the 
fetal scalp until delivery of the fetus through the hys-
terotomy.  If internal monitoring is not possible then 
external monitoring should be used up to the time of 
maternal abdominal prep, which should not be done 
until appropriate anesthesia has been obtained, there-
by decreasing the duration of non-monitoring to the 
smallest amount of time possible. 
e) Confusing the maternal and fetal heart rates.
Most might be surprised how often this occurs.  The 
Iowa Statewide Perinatal Team sees this numerous 
times a year during our visits to the state’s hospitals. 
Unfortunately, some of these end with less than opti-
mal outcomes.  Because of the technology employed in 
external fetal heart rate monitors it is not uncommon 
for the monitor to actually record the maternal and not 
the fetal heart rate.  This problem is unique to external 
monitoring, assuming a living fetus (the maternal heart 
rate can be transmitted through a dead fetus).  Mater-
nal heart rate can, at times, be signifi cantly elevated, 
such as during a maternal fever or with pushing in the 
second stage of labor.  In addition, the fetal heart rate 
may slow during a deceleration.  This may result in the 
monitor becoming “confused” and may start to record 
the maternal heart rate instead of the fetal heart rate. 
Therefore there is continual need for health care pro-
viders to distinguish the maternal heart rate from that 
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of the fetus.  If there is any question, an internal fetal 
monitor should be placed on the fetal scalp and a pulse 
oxymeter on the mother.  This will usually clarify the 
situation.  This is a clinically dangerous situation that 
may lead to a compromised newborn which surprises 
the health care provider and may then also lead to de-
layed or compromised resuscitation of the depressed 
newborn.   A typical pattern seen when the maternal 
heart rate is being recorded instead of the fetal heart 
rate is seen in Figure 1.  When an acceleration of the 
heart rate mirrors the contraction pattern, especially 
during the second stage of labor, suspicion should be 
raised that the monitor has started recording the ma-
ternal heart rate.
High Risk OB Legal Situation #2 —Pitocin and 
Misoprostol (Cytotec) Use
Each hospital must have policies, procedures, and 
protocols developed by nursing and medical staff. 
These should be evaluated and revised on an ongoing 
basis. If the physician requests deviation from the in-
stitution’s policy, procedures, or protocol, ensure that 
the physician writes the order.  Before an induction for 
any indication, clinical or psychosocial, ACOG ( 1995b) 
recommends a risk-benefi t analysis and discussion of 
the advantages and disadvantages with the patient in-
cluding the risk of cesarean birth or the possibility of a 
repeat induction.  Prior to the initiation of the oxytocin 
infusion or cytotec administration a physician or quali-
fi ed nurse should examine the patient vaginally to as-
sure the adequacy of the maternal pelvis as well as the 
position of the fetus.  A 20-minute baseline fetal moni-
toring strip is recommended before initiation of oxyto-
cin.  Although there is no consensus in the literature on 
the ideal oxytocin dosage regimen, (ACOG states that 
the beginning dose may range from 0.5mU/minute to 
6mU/minute, with increasing increments of the same, 
at intervals between 15-40 minutes) available data sup-
port a lower dosage rate of infusion, and SOGC rec-
ommends “using the minimum dose to achieve active 
labor, increasing the dosage no more frequently than 
every 30 minutes and reevaluating the clinical situa-
tion often (every 30-60 minutes) and especially if the 
oxytocin dosage rate reaches 20 mU/min.” The State-
wide Perinatal Program supports a lower dosage ap-
proach to oxytocin use, e.g. initial dose of 1-2 mU/
min., increasing by 1-2 mU/min. every 30-40 minutes. 
Whatever pitocin policy you decide upon, it can be a 
double-edged sword in the case of a bad birth outcome. 
A legal case can be diffi cult to defend if the policy was 
not followed or either the nursing personnel or the 
physicians are not aware of what the policy states.  Re-
member also that any dose of pitocin can cause uterine 
hyperstimulation.  All obstetrical personnel must be 
able to identify uterine hyperstimulation when it oc-
curs.  When encountered the pitocin should be turned 
off until the hyperstimulation has resolved.  
With respect to the use of cytotec in the obstetrical 
arena we recommend that dose of 25 mcg be employed 
when administered vaginally for term inductions.  A 
50 mcg dose can lead to an increased incidence of uter-
ine hyperstimmulation.  In addition, prostaglandins, 
especially misoprostol (cytotec), should not be used in 
any woman with a prior uterine scar, regardless of ges-
tational age or clinical situation due to the increased 
risk of uterine rupture.
High Risk OB Legal Situation #3—VBAC
This topic has been superbly addressed by Dr. Frank 
Zlatnik in previous editions of The Iowa Perinatal Letter
and much of what I discuss here is taken from those 
discussions.  The changing views in the U.S. related to 
VBAC over the past decade have been considered in 
The Iowa Perinatal Letter (“VBAC Revisited: Déjà Vu All 
Over Again,” vol. XIX, no. 3, p. 11, 1998; and “VBAC: 
The Pendulum Swings,” vol. XXI, no. 1, p. 4, 2000) and 
by the American College of Obstetricians and Gynecol-
ogists in the Practice Bulletin #5 published in July 1999 
(“Vaginal Birth After Previous Cesarean Delivery”). 
If VBAC is offered, then, per ACOG recommenda-
tions, the surgical team must be “immediately avail-
able.” The Statewide Perinatal Team interprets “imme-
diately available” to mean in the hospital.
“That physicians should be immediately available 
to provide emergency care” in the woman undergoing 
VBAC has had very signifi cant implications for Iowa 
hospitals. ACOG points out that, as opposed to other 
obstetric complications that may arise without warn-
ing, VBAC attempts to represent elective procedures. If 
a service plans to offer VBAC to its patients, “surgical, 
anesthetic, and nursing support should be available 
when a woman attempting VBAC is in active labor in 
order that prompt cesarean delivery can be undertaken 
should it be required.”  Dr. Zlatnik stated this as “all 
hands on deck.”
“There are trade-offs here as a woman desiring 
VBAC may have to travel from her local facility to a 
center hospital in order to be afforded this opportu-
nity. The delays inherent in additional travel time to 
the hospital for the woman in labor may present ad-
ditional risks.” As ACOG states in the last statement in 
the Summary, “the ultimate decision to attempt VBAC 
or undergo a repeat cesarean delivery is an individual 
one made by the patient and her physician based on 
individual risks, benefi ts, and values.” 
In addition, prostaglandins, especially misoprostol 
(cytotec), should not be used in any woman with a pri-
or uterine scar, regardless of gestational age or clinical 
situation due to the increased risk of uterine rupture.
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Figure 1. Maternal/Fetal Tracing
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Figure 2
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High Risk OB Legal Situation #4—Shoulder 
Dystocia
Shoulder dystocia remains an unpredictable ob-
stetrical emergency and should be anticipated at all 
vaginal deliveries.  The various maneuvers available 
to treat this condition should be well known by all la-
bor and delivery personnel.  Extensive and thorough 
documentation is a must when a shoulder dystocia is 
encountered.  Often the outcome of a legal proceed-
ing involving a shoulder dystocia situation will be de-
termined by the thoroughness of the documentation. 
Several recent articles addressing shoulder dystocia 
have suggested various forms that can be used to en-
sure adequate documentation.  The University of Iowa 
has produced a shoulder dystocia checklist/note to 
aid in this documentation (Figure 2).  In addition to 
thorough documentation, the use of shoulder dystocia 
drills or simulations can aid in teaching obstetrical per-
sonnel how to most effectively and effi ciently respond 
to this low frequency-high acuity event.
High Risk OB Legal Situation #5—Operative 
Vaginal Delivery
Because of the potential legal risks associated with 
a less than optimal outcome after an operative vaginal 
delivery, good documentation, including a preopera-
tive note, should be included in the chart whenever pos-
sible.  Points that should be addressed in a preoperative 
vaginal delivery note include such items as estimated 
fetal weight, adequacy of maternal pelvis, the amount 
of molding, the fetal station, fetal position, fetal heart 
rate pattern, and uterine contraction pattern should be 
addressed.  In addition the indication for the operative 
vaginal trial (ACOG Practice Bulletin #17, June 2000), 
the fact that the patient has been informed of the risks 
of operative vaginal delivery as well as those of ab-
dominal surgery, and that the physician feels that the 
patient is an adequate candidate for operative vaginal 
delivery should also be documented.  In a postopera-
tive note, especially when vacuum has been used, the 
post procedure note should include total pressure ap-
plied, length of duration that the vacuum was applied, 
number of contractions through which pulls were 
done, whether there was or was not fetal decent with 
each attempt, and the number of vacuum pop offs, if 
any.  Any personnel that use a vacuum should also be 
familiar with the manufacturers printed material that 
is provided regarding the device that is used.  I also 
suggest that after any operative vaginal delivery case a 
fetal cord PH be obtained at the time of delivery.
  —Stephen K. Hunter, MD, PhD
  Maternal Fetal Specialist
  Associate Director
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